Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 154 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

154 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 154 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

154 programs

Clinical programs

Page 2 of 4

  1. Feiba

    Takeda

    Hemophilia A With Inhibitor

    approved small molecule active

    1 trial

  2. Ferric carboxymaltose

    Takeda

    Cardiac Failure

    approved small molecule active

    1 trial

  3. Fruquintinib

    Takeda

    Colorectal Cancer

    approved small molecule active

    1 trial

  4. Guanfacine hydrochloride (TAK-503)

    Takeda

    Attention Deficit Hyperactivity Disorder

    approved small molecule completed

    1 trial

  5. HYQVIA

    Takeda

    Primary Immunodeficiency Diseases (PID)

    approved mab completed

    2 trials

  6. Idursulfase

    Takeda

    Hunter Syndrome

    approved mab completed

    2 trials

  7. Ixazomib

    Takeda

    Relapsed and/or Refractory Multiple Myeloma

    approved small molecule terminated

    4 trials

  8. Lansoprazole

    Takeda

    Functional Dyspepsia

    approved small molecule terminated

    1 trial

  9. Lansoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    1 trial

  10. Lansoprazole (Prevacid)

    Takeda

    Zollinger-Ellison Syndrome

    approved small molecule completed

    1 trial

  11. Lanthanum carbonate

    Takeda

    Kidney Failure, Chronic

    approved small molecule completed

    6 trials

  12. Lanthanum carbonate

    Takeda

    Kidney Diseases

    approved small molecule terminated

    2 trials

  13. Leuprorelin

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  14. Leuprorelin Acetate Depot 3M

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  15. Lisdexamfetamine dimesylate

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  16. Lisdexamfetamine dimesylate

    Takeda

    Attention-deficit/Hyperactivity Disorder

    approved small molecule completed

    3 trials

  17. Lubiprostone

    Takeda

    Inflammatory Bowel Disease

    approved small molecule completed

    1 trial

  18. Lubiprostone

    Takeda

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  19. Lubiprostone

    Takeda

    Constipation

    approved small molecule completed

    7 trials

  20. MMX Mesalamine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    2 trials

  21. MMX mesalamine/ mesalazine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    1 trial

  22. Manidipine 20mg

    Takeda

    Hypertension

    approved small molecule terminated

    1 trial

  23. Maribavir

    Takeda

    Transplant Complication

    approved small molecule completed

    1 trial

  24. Metformin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  25. Midodrine HCl

    Takeda

    Orthostatic Hypotension

    approved small molecule completed

    1 trial

  26. Midodrine HCl

    Takeda

    Symptomatic Orthostatic Hypotension

    approved small molecule completed

    1 trial

  27. Midodrine Hydrochloride

    Takeda

    Hypotension, Orthostatic

    approved small molecule completed

    2 trials

  28. Mixed amphetamine salts (ADDERALL XR)

    Takeda

    ADHD

    approved small molecule completed

    1 trial

  29. NESINA ACT TAB. 25/15mg

    Takeda

    Diabetes

    approved small molecule active

    1 trial

  30. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial

  31. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  32. Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

    Takeda

    Hemophilia A

    approved mab completed

    2 trials

  33. Pantoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    2 trials

  34. Pantoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    3 trials

  35. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial

  36. Pioglitazone

    Takeda

    Nonalcoholic Steatohepatitis

    approved small molecule completed

    1 trial

  37. Pioglitazone

    Takeda

    Bone Metabolism

    approved small molecule completed

    1 trial

  38. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials

  39. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  40. Pioglitazone

    Takeda

    Metabolic Syndrome

    approved small molecule completed

    1 trial

  41. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  42. Pioglitazone

    Takeda

    Type II Diabetes Mellitus

    approved small molecule completed

    1 trial

  43. Pioglitazone 15mg

    Takeda

    Inflammation

    approved small molecule completed

    1 trial

  44. Pioglitazone and insulin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    2 trials

  45. Pioglitazone and metformin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    5 trials

  46. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial

  47. Placebo

    Takeda

    Chronic Insomnia

    approved small molecule terminated

    1 trial

  48. Placebo

    Takeda

    Post-Traumatic Stress Disorder

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

154 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.